Detalles de la búsqueda
1.
Prognostic Role of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma: A Large, Multicenter, Prospective Trial.
Oncologist
; 26(9): 740-750, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34077597
2.
CHIR99021, trough GSK-3ß Targeting, Reduces Epithelioid Sarcoma Cell Proliferation by Activating Mitotic Catastrophe and Autophagy.
Int J Mol Sci
; 22(20)2021 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34681807
3.
Association between neutropenia and response to ramucirumab and paclitaxel in patients with metastatic gastric cancer.
Anticancer Drugs
; 31(6): 632-636, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32011363
4.
A Vismodegib Experience in Elderly Patients with Basal Cell Carcinoma: Case Reports and Review of the Literature.
Int J Mol Sci
; 21(22)2020 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33202689
5.
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial.
BMC Med
; 17(1): 207, 2019 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31747948
6.
Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results.
J Transl Med
; 17(1): 296, 2019 08 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31464635
7.
The influence of prior ramucirumab treatment on the clinical activity of FOLFIRI as third-line therapy in patients with metastatic gastric Cancer.
Invest New Drugs
; 37(3): 524-530, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30687871
8.
Poor outcome for patients with gastric cancer and lung metastases treated with ramucirumab and paclitaxel.
Anticancer Drugs
; 30(7): e0789, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31305296
9.
Anti-PD-1 versus anti-PD-L1 therapy in patients with pretreated advanced non-small-cell lung cancer: a meta-analysis.
Future Oncol
; 15(20): 2423-2433, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31237152
10.
Gene Copy Number and Post-Transductional Mechanisms Regulate TRAP1 Expression in Human Colorectal Carcinomas.
Int J Mol Sci
; 21(1)2019 Dec 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31878280
11.
Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer.
Invest New Drugs
; 36(6): 1133-1137, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30083960
12.
Corticosteroid switch in heavily pre-treated castration-resistant prostate cancer patients progressed on abiraterone acetate plus prednisone.
Invest New Drugs
; 36(6): 1110-1115, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30345466
13.
The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale).
BMC Cancer
; 18(1): 552, 2018 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29747595
14.
Lower urinary tract infections from external beam radiation therapy in prostate cancer: A single institution experience.
Rep Pract Oncol Radiother
; 23(4): 298-299, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30100818
15.
Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone.
Prostate
; 77(9): 1012-1019, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28429372
16.
Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer.
Future Oncol
; 12(4): 493-502, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26776493
17.
Crizotinib-induced cardiotoxicity: the importance of a proactive monitoring and management.
Future Oncol
; 11(14): 2043-8, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26198834
18.
A multicenter phase II trial of nab-paclitaxel and capecitabine in HER-2 negative and triple- negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?
Breast J
; 26(9): 1857-1859, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32436244
19.
Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial.
Lancet Oncol
; 15(7): 713-21, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24831979
20.
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: results from the Italian national registry.
Biol Blood Marrow Transplant
; 20(4): 501-6, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24374214